Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Jayamas Medica Industri Tbk. (OMED) Price & Performance

UBC Medical Indonesia Tbk.Trade
Jayamas Medica Industri Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Jayamas Medica Industri Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume), while Jayamas Medica Industri Tbk. trades at Rp228 (market cap 6.33T, 1.27M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 9.7× UBC Medical Indonesia Tbk.'s market cap, and Jayamas Medica Industri Tbk. is more actively traded (1.27M versus 626.9K). Which is the better fit depends on your goals.

LABSOMED
Market Cap
651.75B6.33T
Volume
626.9K1.27M
Lot
6.27K12.74K
Turnover
103.6M293.7M
Average Price
165.25230.46
Value
103.6M293.7M
Indicative Equilibrium Price
165234
Indicative Equilibrium Volume
3005.8K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
OMED
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Jayamas Medica Industri Tbk.

PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.

Read more on OMED